ARGENX SE is 1.7x more valuable than Revolution Medicines, Inc. by market capitalization ($55.29 B vs $32.71 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARGX | RVMD |
|---|---|---|
| Market cap | $55.29 B | $32.71 B |
| US-listed rank | #303 | #439 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | - | -$1.13B |
| SEC filings | 272 | 782 |
ARGENX SE is 1.7x more valuable than Revolution Medicines, Inc. by market capitalization ($55.29 B vs $32.71 B).
Full pages: ARGENX SE and Revolution Medicines, Inc., or browse the full rankings.